Investigating cardiovascular markers in women with PCOS during glucose testing
Official title: The Effect of Different Treatment Options on Markers of Vascular, Myocardial and Endothelial Function in Women With Polycystic Ovary Syndrome and the Association With Metabolic and Hormonal Abnormalities of the Syndrome
Run by Attikon Hospital · NCT06889454 · Data updated 2026-11-12
This study is testing how glucose testing affects heart health markers in women with PCOS and whether different treatments can improve those markers over six months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Attikon Hospital Academic / other |
| Locations | 1 site (Chaïdári) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | February 1, 2025 |
| Study ends | February 1, 2026 |
| Registry record updated | November 19, 2025 |
| Trial ID | NCT06889454 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women over 16 years old with a diagnosis of PCOS who have not received treatment for the condition in the past six months.
✕Probably not a fit
Patients with conditions mimicking PCOS, such as thyroid disease or type 2 diabetes, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore cardiovascular and endothelial function markers in women diagnosed with PCOS during an oral glucose tolerance test (OGTT). Participants will undergo measurements of glucose, insulin, and various cardiovascular parameters at specific intervals during the OGTT. Additionally, the study will assess the impact of treatment interventions such as GLP-1 receptor agonists, oral contraceptives, and lifestyle modifications on these markers over a six-month period. The primary endpoints focus on changes in global longitudinal strain, pulse wave velocity, and perfused boundary region during the OGTT and after treatment.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of cardiovascular risks in women with PCOS.
How similar studies have gone: While there have been studies on cardiovascular risks in PCOS, this specific approach focusing on acute changes during OGTT is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age \> 16 years old 2. Diagonis of PCOS according to Rotterdam criteria: presence of two of the three of the following: * Clinical or biochemical hyperandrogenism * Anovulation or oligo-ovulation * Polycystic ovarian morphology (PCOM) 3. Absence of treatment for PCOS the last six months 4. Patients who have the ability to understand and sign the consent form. Exclusion Criteria: 1. Disorders with clinical presentation similar to PCOS: thyroid disease, hyperprolactinemia, and non-classic congenital adrenal hyperplasia (primarily 21-hydroxylase deficiency by serum 17-hydroxyprogesterone \[17-OHP\]), Cushing syndrome, acromegaly 2. Treatment with contraceptive or metformin 3. Type 2 diabetes mellitus 4. Treatment for diabetes 5. Pregnancy 6. Lactation 7. Malignancy
Where it's running
-
Attikon University General Hospital
Chaïdári, Greece Recruiting
Study contacts
- Study coordinator: VAIA lAMBADIARI, Professor
- Email: vlambad@otenet.gr
- Phone: 2105831148
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating fasting insulin and insulin resistance across different demographics
This study looks at how fasting insulin levels and insulin resistance vary among different groups of people based on age, sex, race, weight, and conditions like PCOS to better understand metabolic health.
-
Study on the health effects of children born to mothers with PCOS
This study looks at how being born to mothers with Polycystic Ovary Syndrome (PCOS) affects children's health both now and in the future.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.